METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages

Clinical Immunology

Volumn 156, Issue 2, 2015, Pages 119-127

  Ushach, Irina ^a   Burkhardt, Amanda M ^a   Martinez, Cynthia ^b   Hevezi, Peter A ^a   Gerber, Peter Arne ^b   Buhren, Bettina Alexandra ^b   Schrumpf, Holger ^b   Valle Rios, Ricardo ^a,c   Vazquez, Monica I ^a   Homey, Bernhard ^b   Zlotnik, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Children's Hospital of Mexico Federico Gómez   (Mexico)

Author keywords

Cytokine; M2 macrophages; Meteorin like; Psoriasis; Rheumatoid arthritis; Skin

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; METEORIN LIKE; UNCLASSIFIED DRUG; COMETIN PROTEIN, MOUSE; NERVE GROWTH FACTOR;

ACTINIC KERATOSIS; ACTIVATED MACROPHAGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BIOINFORMATICS; BONE MARROW; CONTROLLED STUDY; FIBROBLAST; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MACROPHAGE; MOUSE; MUCOSA; NEURODERMATITIS; NONHUMAN; PSORIASIS; RHEUMATOID ARTHRITIS; SKIN; SKIN DISEASE; SYNOVIUM; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PRURIGO; UPREGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; DERMATITIS, ATOPIC; ENDOTHELIAL CELLS; HUMANS; KERATINOCYTES; KERATOSIS, ACTINIC; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NERVE GROWTH FACTORS; PRURIGO; PSORIASIS; SKIN; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 84920092312     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.11.006     Document Type: Article

References (46)

1. Oppenheim J.J. Cytokines: past, present, and future. Int. J. Hematol. 2001, 74:3-8.
2. Dinarello C.A. Historical insights into cytokines. Eur. J. Immunol. 2007, 37(Suppl. 1):S34-S45.
3. O'Shea J.J., Kanno Y., Chan A.C. In search of magic bullets: the golden age of immunotherapeutics. Cell 2014, 157:227-240.
4. Lee J., Hever A., Willhite D., Zlotnik A., Hevezi P. Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J. 2005, 19:1356-1358.
5. Roth R.B., Hevezi P., Lee J., Willhite D., Lechner S.M., Foster A.C., Zlotnik A. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 2006, 7:67-80.
6. Luu V.P., Hevezi P., Vences-Catalan F., Maravillas-Montero J.L., White C.A., Casali P., Llorente L., Jakez-Ocampo J., Lima G., Vilches-Cisneros N., Flores-Gutierrez J.P., Santos-Argumedo L., Zlotnik A. TSPAN33 is a novel marker of activated and malignant B cells. Clin. Immunol. 2013, 149:388-399.
7. Valle-Rios R., Maravillas-Montero J.L., Burkhardt A.M., Martinez C., Buhren B.A., Homey B., Gerber P.A., Robinson O., Hevezi P., Zlotnik A. ISM1 is a novel secreted protein expressed in skin, mucosal tissues and NK, NKT and Th17 cells. J. Interferon Cytokine Res. 2014, 34:795-801.
8. Lacey D.C., Achuthan A., Fleetwood A.J., Dinh H., Roiniotis J., Scholz G.M., Chang M.W., Beckman S.K., Cook A.D., Hamilton J.A. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 2012, 188:5752-5765.
9. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
10. Hevezi P., Moyer B.D., Lu M., Gao N., White E., Echeverri F., Kalabat D., Soto H., Laita B., Li C., Yeh S.A., Zoller M., Zlotnik A. Genome-wide analysis of gene expression in primate taste buds reveals links to diverse processes. PLoS One 2009, 4:e6395.
11. Gerber P.A., Hevezi P., Buhren B.A., Martinez C., Schrumpf H., Gasis M., Grether-Beck S., Krutmann J., Homey B., Zlotnik A. Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins. PLoS One 2013, 8:e63949.
12. Homey B., Wang W., Soto H., Buchanan M.E., Wiesenborn A., Catron D., Muller A., McClanahan T.K., Dieu-Nosjean M.C., Orozco R., Ruzicka T., Lehmann P., Oldham E., Zlotnik A. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol. 2000, 164:3465-3470.
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
14. Soto H., Hevezi P., Roth R.B., Pahuja A., Alleva D., Acosta H.M., Martinez C., Ortega A., Lopez A., Araiza-Casillas R., Zlotnik A. Gene array analysis comparison between rat collagen-induced arthritis and human rheumatoid arthritis. Scand. J. Immunol. 2008, 68:43-57.
15. Nishino J., Yamashita K., Hashiguchi H., Fujii H., Shimazaki T., Hamada H. Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension. EMBO J. 2004, 23:1998-2008.
16. Lee H.S., Han J., Lee S.H., Park J.A., Kim K.W. Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway. J. Cell Sci. 2010, 123:1959-1968.
17. Wang Z., Andrade N., Torp M., Wattananit S., Arvidsson A., Kokaia Z., Jorgensen J.R., Lindvall O. Meteorin is a chemokinetic factor in neuroblast migration and promotes stroke-induced striatal neurogenesis. J. Cereb. Blood Flow Metab. 2012, 32:387-398.
18. Jorgensen J.R., Thompson L., Fjord-Larsen L., Krabbe C., Torp M., Kalkkinen N., Hansen C., Wahlberg L. Characterization of Meteorin-an evolutionary conserved neurotrophic factor. J. Mol. Neurosci. 2009, 39:104-116.
19. Li Z.Y., Zheng S.L., Wang P., Xu T.Y., Guan Y.F., Zhang Y.J., Miao C.Y. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci. Ther. 2014, 20:344-354.
20. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4828-4832.
21. Schmid M.A., Kingston D., Boddupalli S., Manz M.G. Instructive cytokine signals in dendritic cell lineage commitment. Immunol. Rev. 2010, 234:32-44.
22. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
23. Fleetwood A.J., Lawrence T., Hamilton J.A., Cook A.D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 2007, 178:5245-5252.
24. Choi S.S., Gatanaga M., Granger G.A., Gatanaga T. Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cell. Immunol. 1996, 170:178-184.
25. Tanaka A., Lai-Cheong J.E., van den Akker P.C., Nagy N., Millington G., Diercks G.F., van Voorst Vader P.C., Clements S.E., Almaani N., Techanukul T., Hide M., South A.P., McGrath J.A. The molecular skin pathology of familial primary localized cutaneous amyloidosis. Exp. Dermatol. 2010, 19:416-423.
26. Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
27. Palfreeman A.C., McNamee K.E., McCann F.E. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast. Drug Des. Dev. Ther. 2013, 7:201-210.
28. Rao R.R., Long J.Z., White J.P., Svensson K.J., Lou J., Lokurkar I., Jedrychowski M.P., Ruas J.L., Wrann C.D., Lo J.C., Camera D.M., Lachey J., Gygi S., Seehra J., Hawley J.A., Spiegelman B.M. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014, 157:1279-1291.
29. Bowcock A.M., Krueger J.G. Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 2005, 5:699-711.
30. Buckner J.H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 2010, 10:849-859.
31. Djemadji-Oudjiel N., Goerdt S., Kodelja V., Schmuth M., Orfanos C.E. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch. Dermatol. Res. 1996, 288:757-764.
32. Berke R., Singh A., Guralnick M. Atopic dermatitis: an overview. Am. Fam. Physician 2012, 86:35-42.
33. Schmitt J., Langan S., Deckert S., Svensson A., von Kobyletzki L., Thomas K., Spuls P. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J. Allergy Clin. Immunol. 2013, 132:1337-1347.
34. Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int. Arch. Allergy Immunol. 2005, 137:319-325.
35. Brandt E.B., Sivaprasad U. Th2 cytokines and atopic dermatitis. J. Clin. Cell. Immunol. 2011, 2.
36. Di Cesare A., Di Meglio P., Nestle F.O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis?. J. Investig. Dermatol. 2008, 128:2569-2571.
37. Eyerich K., Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013, 68:974-982.
38. Eyerich K., Pennino D., Scarponi C., Foerster S., Nasorri F., Behrendt H., Ring J., Traidl-Hoffmann C., Albanesi C., Cavani A. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J. Allergy Clin. Immunol. 2009, 123:59-66. (e54).
39. Heath W.R., Carbone F.R. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat. Immunol. 2013, 14:978-985.
40. Singh A., Morris R.J. Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?. Exp. Dermatol. 2012, 21:660-664.
41. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.
42. Pasparakis M., Haase I., Nestle F.O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 2014, 14:289-301.
43. Novelli L., Chimenti M.S., Chiricozzi A., Perricone R. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies. Autoimmun. Rev. 2014, 13:64-69.
44. Nomenclature for secreted regulatory proteins of the immune system (interleukins). WHO-IUIS Nomenclature Subcommittee on Interleukin Designation. Eur. Cytokine Netw. 1991, 2:309-310.
45. Locati M., Mantovani A., Sica A. Macrophage activation and polarization as an adaptive component of innate immunity. Adv. Immunol. 2013, 120:163-184.
46. Clavel G., Thiolat A., Boissier M.C. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine 2013, 80:449-453.